Microbio announces new status as an unlisted Public Company

Queensland’s Microbio has become an unlisted public company in a move to position the biotechnology scale-up for expansion into international markets. This move to public company status coincided with the company’s recent CE Mark of approval for the use of its revolutionary Bloodstream Infection test, Microbio InfectID-BSI in Europe. Read more in the media release:… Continue reading Microbio announces new status as an unlisted Public Company